Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Arconic (ARNC) initiated with a Neutral at JPMorgan. 2. Priceline (PCLN) coverage transferred with an Outperform at Macquarie. 3. Interpublic Group (IPG) was initiated with an Outperform at Evercore ISI while Omnicom (OMC) was initiated with an In Line. 4. Alteryx (AYX) was initiated with an Outperform at William Blair, Raymond James, JMP Securities, and Cowen, an Overweight at Pacific Crest, a Buy at Goldman Sachs, and a Neutral at JPMorgan. 5. Synacor (SYNC) initiated with a Buy on upcoming growth at Canaccord. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

Argus analyst Kristina Ruggeri raised the firm's price target on Omnicom to $103 from $97 and keeps a Buy rating on the shares. The company's recent acquisition of Flywheel Digital will provide a competitive advantage for the company and near real-time performance measurement of campaigns for its clients, the analyst tells investors in a research note. Omnicom is also positioning itself as a leader in AI tools, which will enable its agency teams to do their jobs more efficiently and focus on high-impact work for clients, while is distribution yield of about 3% is "attractive", the firm added.

New option listings for April 23rd include Express Inc (EXPRQ). Option delistings effective April 23rd include PGT Innovations Inc (PGTI), NGM Biopharmaceuticals Inc (NGM), Karuna Therapeutics Inc (KRTX), KINNATE BIOPHARMA INC (KNTE), Daseke Inc (DSKE), Tritium Dcfc Ltd (DCFC), Xtrackers MSCI All China Equity ETF (CN), CymaBay Therapeutics Inc (CBAY), Alteryx Inc (AYX), XTRACKERS MSCI CHINA A INCLUSION EQUITY ETF (ASHX), Recro Pharma, Inc. (SCTL), Splunk Inc (SPLK), and Textainer Group Holdings Limited (TGH).